Rare complications of diphenhydramine toxicity.

University of Connecticut Health Center, Farmington, USA.
Connecticut medicine 03/2008; 72(2):79-82.
Source: PubMed

ABSTRACT Antihistamines have traditionally been regarded as safe over the counter sedative-hypnotics. While they are generally considered to have a wide safety profile, there have been multiple reports of severe toxicity and even fatalities associated with antihistamine overdoses, most of them associated with suicide attempts. We present the case of a 33-year-old female who attempted suicide by ingesting diphenhydramine pills and had a course complicated by two rarely observed adverse effects of antihistamines: rhabdomyolysis and a prolonged QT interval on EKG. Both rhabdomyolysis and a prolonged QT have been observed in cases of antihistamine overdose, but to our knowledge this is the first case with both of these complications occurring together in the same patient. We postulate the mechanisms of action by which diphenhydramine may cause these two potentially life threatening adverse effects.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diphenhydramine toxicity commonly manifests with antimuscarinic features, including dry mucous membranes, tachycardia, urinary retention, mydriasis, tachycardia, and encephalopathy. Severe toxicity can include seizures and intraventricular conduction delay. We present here a case of a 23-year-old male presenting with recurrent seizures, hypotension and wide complex tachycardia who had worsening toxicity despite treatment with sodium bicarbonate. The patient was ultimately treated with intravenous lipid emulsion therapy that was temporally associated with improvement in the QRS duration. We also review the current literature that supports lipid use in refractory diphenhydramine toxicity.
    The western journal of emergency medicine 11/2014; 15(7):855-8. DOI:10.5811/westjem.2014.8.23407
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report the case of an adolescent with anticholinergic toxidrome from diphenhydramine overdose, whose symptoms were treated with a novel application of dexmedetomidine.
    Journal of medical toxicology: official journal of the American College of Medical Toxicology 06/2014; 10(4). DOI:10.1007/s13181-014-0408-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: The following paper reviews the latest news on antihistamines used in the treatment of allergic rhinitis. It describes the new results of investigations on clinical application of H3 and H4 receptors in therapy of allergic diseases as well as the effect of emedastine on histamine-induced tissue remodeling. Contemporary clinical research of these drugs fulfills the requirements of placebo-controlled trials, including the comparison with a reference drug, usually cetirizine. The paper discusses efficacy and safety of a new drug--bilastine, and the possibility to improve clinical outcome by combining antihistamine drugs with inhaled glucocorticosteroids and antileukotrienes. It also presents the studies on high efficacy of nasal antihistamines, which most probably results from their high concentration in inflamed tissue, as well as describes the latest news on safe use of antihistamines, including studies of fexofenadine enantiomers in drug interactions with P-glycoprotein, safety of a new antihistamine medication--rupatadine, and psychostimulating effect of some other antihistamines. The review shows that antihistamines, the most frequently used class of anti-allergy medications, have been constantly improved, which is of significant importance for progress of allergic diseases treatment.
    Otolaryngologia polska. The Polish otolaryngology 09/2009; 63(7):5-10.